Aug 14, 2023
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.03 to $0.00.
The split itself did not change the total investment value.
RegeneRx Biopharmaceuticals, Inc. (RGRX) trades on the Other OTC in the Biotechnology industry.
RegeneRx Biopharmaceuticals, Inc. company overviewThe latest split shown was on August 14, 2023. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
This history records one reverse split, on August 14, 2023.